$HTGC News

Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Third Quarter 2026

Hercules Capital (HTGC) Stock Still Looks Undervalued After A 63% Five Year Run

Hercules Capital (HTGC), What Is Driving Fresh Attention Now?

Hercules Capital: Close To A Buy, But Not Before Q3 2026

Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors

3 Private Credit Stocks Cut Their Dividends. Are Blackstone and Hercules Next?

Hercules Capital: This Juicy 11.5% Yield Is On Sale

Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.

Hercules Capital (HTGC) Exceeds Market Returns: Some Facts to Consider

Hercules Capital Announces Date for Release of Third Quarter 2026 Financial Results and Conference Call

Hercules Capital: Rate Hike Could Bring The Costs Without The Income; Downgrade To Sell

Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors

Hercules Capital Closes Institutional Notes Offering of $400.0 Million 6.700% Notes due 2029

Rocket Pharmaceuticals shares rise 4% after securing access to $150 million credit facility

Hercules Capital Prices Upsized Institutional Notes Offering of $400.0 Million 6.70% Notes due 2029

Hercules Capital Prices Upsized Public Offering Of $400M, 6.70% Notes Due 2029

Hercules Capital (HTGC) Stock May Still Be A Bargain On Equity Returns

2 Reasons HTGC is Risky and 1 Stock to Buy Instead

Is Hercules Capital (HTGC) Undervalued As Its Board Adds A New Audit Director?

NorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer Therapies